Rehospitalization, mortality and associated variables in primary care patients with heart failure and preserved ejection fraction after first hospitalization
Victoria Cendrós , Mar Domingo , Elena Navas , Miguel Ángel Muñoz , Antoni Bayés-Genís , José María Verdú-Rotellar
{"title":"Rehospitalization, mortality and associated variables in primary care patients with heart failure and preserved ejection fraction after first hospitalization","authors":"Victoria Cendrós , Mar Domingo , Elena Navas , Miguel Ángel Muñoz , Antoni Bayés-Genís , José María Verdú-Rotellar","doi":"10.1016/j.ijcrp.2025.200391","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>There is a paucity of studies providing insights into the progression of primary care patients with heart failure and preserved ejection fraction (HFpEF).</div></div><div><h3>Objetive</h3><div>To investigate the characteristics associated with mortality and rehospitalizations in primary care patients with heart failure and preserved ejection fraction (HFpEF), previously hospitalized.</div></div><div><h3>Methods</h3><div>Retrospective cohort study that included primary care patients with previous heart failure (HF) hospitalization and ejection fraction ≥50 of 328 primary care centers of Catalonia. Demographic, comorbidities, clinical, and treatment variables were collected. Outocomes: Mortality and HF rehospitalization. Adjusted Cox regression models were performed.</div></div><div><h3>Results</h3><div>Study included 2895 patients. Mean age was 77(SD 9.7) years, 57 % were female. Mean follow up was 2.0[1.0–9.0] years. A total of 864(29.8 %) patients died, 831(28.7 %) were hospitalized. Mortality was associated with male sex(HR 1.26, 95 % CI 1.06–1.49), age >75 years(HR 2.76, 95 % CI 2.24–3.39), Charlson Index(HR 2.03, 95 % CI 1.21–3.42), body mass index(BMI) ≤30 kg/m<sup>2</sup>(HR 1.44, 95 % CI 1.22–1.69) and loop diuretics(HR 1.36, 95 % CI 1.11–1.65); hemoglobin levels(HR 0.87, 95 % CI 95 % 0.82–0.91) were protective. HF rehospitalization was associated with male sex(HR 1.14, 95 % CI 1.03–1.33), age >75 years(HR 1.37, 95 % CI 1.17–1.61), atrial fibrillation(HR 1.44, 95 % CI 1.25–1.67), and loop diuretics(HR 1.37, 95 % CI 1.15–1.63). Hemoglobin(HR 0.91, 95 % CI 0.87–0.95) were protective.</div></div><div><h3>Conclusion</h3><div>High proportion of HFpEF patients were hospitalized or died at 5 years follow up. Comorbidities, demographic, analytical and treatment variables played a relevant role as prognostic factors.</div></div>","PeriodicalId":29726,"journal":{"name":"International Journal of Cardiology Cardiovascular Risk and Prevention","volume":"25 ","pages":"Article 200391"},"PeriodicalIF":1.9000,"publicationDate":"2025-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cardiology Cardiovascular Risk and Prevention","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772487525000297","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
There is a paucity of studies providing insights into the progression of primary care patients with heart failure and preserved ejection fraction (HFpEF).
Objetive
To investigate the characteristics associated with mortality and rehospitalizations in primary care patients with heart failure and preserved ejection fraction (HFpEF), previously hospitalized.
Methods
Retrospective cohort study that included primary care patients with previous heart failure (HF) hospitalization and ejection fraction ≥50 of 328 primary care centers of Catalonia. Demographic, comorbidities, clinical, and treatment variables were collected. Outocomes: Mortality and HF rehospitalization. Adjusted Cox regression models were performed.
Results
Study included 2895 patients. Mean age was 77(SD 9.7) years, 57 % were female. Mean follow up was 2.0[1.0–9.0] years. A total of 864(29.8 %) patients died, 831(28.7 %) were hospitalized. Mortality was associated with male sex(HR 1.26, 95 % CI 1.06–1.49), age >75 years(HR 2.76, 95 % CI 2.24–3.39), Charlson Index(HR 2.03, 95 % CI 1.21–3.42), body mass index(BMI) ≤30 kg/m2(HR 1.44, 95 % CI 1.22–1.69) and loop diuretics(HR 1.36, 95 % CI 1.11–1.65); hemoglobin levels(HR 0.87, 95 % CI 95 % 0.82–0.91) were protective. HF rehospitalization was associated with male sex(HR 1.14, 95 % CI 1.03–1.33), age >75 years(HR 1.37, 95 % CI 1.17–1.61), atrial fibrillation(HR 1.44, 95 % CI 1.25–1.67), and loop diuretics(HR 1.37, 95 % CI 1.15–1.63). Hemoglobin(HR 0.91, 95 % CI 0.87–0.95) were protective.
Conclusion
High proportion of HFpEF patients were hospitalized or died at 5 years follow up. Comorbidities, demographic, analytical and treatment variables played a relevant role as prognostic factors.
关于心力衰竭和保留射血分数(HFpEF)的初级保健患者进展的研究缺乏。目的探讨曾住院的初级保健心力衰竭和保留射血分数(HFpEF)患者的死亡率和再住院的相关特征。方法回顾性队列研究纳入加泰罗尼亚328个初级保健中心既往心力衰竭(HF)住院且射血分数≥50的初级保健患者。收集了人口统计学、合并症、临床和治疗变量。结果:死亡率和心衰再住院。采用调整后的Cox回归模型。结果纳入2895例患者。平均年龄77岁(SD 9.7),女性占57%。平均随访时间为2.0年[1.0 ~ 9.0]年。死亡864例(29.8%),住院831例(28.7%)。死亡率与男性(HR 1.26, 95% CI 1.06-1.49)、年龄(75岁)(HR 2.76, 95% CI 2.24-3.39)、Charlson指数(HR 2.03, 95% CI 1.21-3.42)、体重指数(BMI)≤30 kg/m2(HR 1.44, 95% CI 1.22-1.69)和袢利尿剂(HR 1.36, 95% CI 1.11-1.65)相关;血红蛋白水平(HR 0.87, 95% CI 95% 0.82-0.91)具有保护作用。HF再住院与男性(HR 1.14, 95% CI 1.03-1.33)、年龄(75岁)(HR 1.37, 95% CI 1.17-1.61)、房颤(HR 1.44, 95% CI 1.25-1.67)和袢利尿剂(HR 1.37, 95% CI 1.15-1.63)相关。血红蛋白(HR 0.91, 95% CI 0.87-0.95)具有保护作用。结论HFpEF患者在随访5年时住院或死亡的比例较高。合并症、人口统计学、分析和治疗变量作为预后因素发挥了相关作用。